GlassScriptPhysician profile
Lynn M Klein
NPI 1720147861
$1,463.33
in general payments reported to CMS, 2019-2025
14 companies · $31.75 in 2025
The $31.75 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $141 · 2020: $395 · 2021: $120 · 2022: $208 · 2023: $218 · 2024: $351 · 2025: $31.75.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $600.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $600.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $405.06 | 2021-2024 | Tremfya |
| Merz North America, INC. | $371.00 | 2020 | |
| Allergan, INC. | $240.54 | 2019-2022 | |
| Abbvie INC. | $178.13 | 2023-2024 | |
| Leo Pharma INC. | $50.53 | 2021-2023 | Adbry |
| Incyte Corporation | $48.10 | 2021-2024 | Opzelura |
| Revance Therapeutics, INC. | $35.57 | 2024-2025 | Daxxify |
| Galderma Laboratories, L.P. | $30.59 | 2019-2024 | Dysport |
| Amgen INC. | $20.92 | 2024 | Otezla |
| Verrica Pharmaceuticals INC. | $18.54 | 2024 | Ycanth |
| Botanix Sb INC | $18.03 | 2025 | Sofdra |
| Strata Skin Sciences, INC. | $15.92 | 2024 | Xtrac |
| Genzyme Corporation | $15.58 | 2024 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $14.82 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lynn Klein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.